by admin | Jun 28, 2019 | Medical, Recent Sepsis News
Last year we wrote about our partnership with Beckman Coulter and the great work they are doing in the field of sepsis diagnostics. We are happy to announce that Beckman Coulter recently received FDA 510(k) clearance for their novel monocyte-based sepsis test called...
by admin | Mar 13, 2019 | Medical, Recent Sepsis News
One of the most significant challenges in the management of sepsis is diagnosing it accurately and early when appropriate interventions can have the greatest impact. Clinicians, especially those working in emergency departments where most sepsis cases enter the...
by admin | Sep 4, 2018 | Medical
As many of you know, September is Sepsis Awareness month, a time dedicated to raising public sepsis awareness and improving sepsis prevention and management efforts in the healthcare community. One day during this month is declared World Sepsis Day, a day when...
by admin | Aug 23, 2018 | Medical
In April of 2018, the Surviving Sepsis Campaign (SSC) released a new version of its popular and widely used Sepsis Management Bundles. These bundles outline the initial sepsis treatment steps recommended by the SSC. The new guideline combines the 7 steps found in the...
by admin | May 4, 2018 | Medical
As many of our users have likely already noticed, our Sepsis app now has a sponsor and we’re very happy about it! Beckman Coulter has generously agreed to support our continued sepsis education efforts, and we want to take this opportunity to welcome them to the...
by admin | Dec 22, 2017 | Medical
The US Food and Drug Administration (FDA) has approved an angiotensin II intravenous formulation (Giapreza, La Jolla Pharmaceutical Co) for the treatment of hypotension in adults with refractory distributive and septic shock not responsive to IV fluids and other...
